Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of low-risk upper tract urothelial carcinoma

Rao S. Mandalapu, Mesut Remzi, Theo M. de Reijke, Vitaly Margulis, J. Palou, A. Kapoor, Ofer Yossepowitch, Jonathan Coleman, Olivier Traxer, J. Kyle Anderson, James Catto, Jean de la Rosette, Timothy O’Brien, Anthony Zlotta, Surena F. Matin

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Introduction: The conservative management of upper tract urothelial carcinoma (UTUC) has historically been offered to patients with imperative indications. The recent International Consultation on Urologic Diseases (ICUD) publication on UTUC stratified treatment allocations based on high- and low-risk groups. This report updates the conservative management of the low-risk group. Methods: The ICUD for low-risk UTUC working group performed a thorough review of the literature with an assessment of the level of evidence and grade of recommendation for a variety of published studies in this disease space. We update these publications and provide a summary of that original report. Results: There are no prospective randomized controlled studies to support surgical management guidelines. A risk-stratified approach based on clinical, endoscopic, and biopsy assessment allows selection of patients who could benefit from kidney-preserving procedures with oncological outcomes potentially similar to radical nephroureterectomy with bladder cuff excision, with the added benefit of renal function preservation. These treatments are aided by the development of high-definition flexible digital URS, multi-biopsies with the aid of access sheaths and other tools, and promising developments in the use of adjuvant topical therapy. Conclusions: Recent developments in imaging, minimally invasive techniques, multimodality approaches, and adjuvant topical regimens and bladder cancer prevention raise the hope for improved risk stratification and may greatly improve the endoscopic treatment for low-risk UTUC.

Original languageEnglish (US)
Pages (from-to)1-11
Number of pages11
JournalWorld Journal of Urology
DOIs
StateAccepted/In press - May 27 2016

Fingerprint

Urologic Diseases
Referral and Consultation
Carcinoma
Therapeutics
Publications
Hope
Kidney
Biopsy
Urinary Bladder Neoplasms
Patient Selection
Urinary Bladder
Guidelines

Keywords

  • Calyces
  • Nephroureterectomy
  • Renal pelvis
  • Upper tract
  • Ureteroscopy
  • Urothelial cancer

ASJC Scopus subject areas

  • Urology

Cite this

Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016 : treatment of low-risk upper tract urothelial carcinoma. / Mandalapu, Rao S.; Remzi, Mesut; de Reijke, Theo M.; Margulis, Vitaly; Palou, J.; Kapoor, A.; Yossepowitch, Ofer; Coleman, Jonathan; Traxer, Olivier; Anderson, J. Kyle; Catto, James; de la Rosette, Jean; O’Brien, Timothy; Zlotta, Anthony; Matin, Surena F.

In: World Journal of Urology, 27.05.2016, p. 1-11.

Research output: Contribution to journalArticle

Mandalapu, RS, Remzi, M, de Reijke, TM, Margulis, V, Palou, J, Kapoor, A, Yossepowitch, O, Coleman, J, Traxer, O, Anderson, JK, Catto, J, de la Rosette, J, O’Brien, T, Zlotta, A & Matin, SF 2016, 'Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of low-risk upper tract urothelial carcinoma', World Journal of Urology, pp. 1-11. https://doi.org/10.1007/s00345-016-1859-6
Mandalapu, Rao S. ; Remzi, Mesut ; de Reijke, Theo M. ; Margulis, Vitaly ; Palou, J. ; Kapoor, A. ; Yossepowitch, Ofer ; Coleman, Jonathan ; Traxer, Olivier ; Anderson, J. Kyle ; Catto, James ; de la Rosette, Jean ; O’Brien, Timothy ; Zlotta, Anthony ; Matin, Surena F. / Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016 : treatment of low-risk upper tract urothelial carcinoma. In: World Journal of Urology. 2016 ; pp. 1-11.
@article{f5f1178ddbe647a2a7fce7db3e797498,
title = "Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of low-risk upper tract urothelial carcinoma",
abstract = "Introduction: The conservative management of upper tract urothelial carcinoma (UTUC) has historically been offered to patients with imperative indications. The recent International Consultation on Urologic Diseases (ICUD) publication on UTUC stratified treatment allocations based on high- and low-risk groups. This report updates the conservative management of the low-risk group. Methods: The ICUD for low-risk UTUC working group performed a thorough review of the literature with an assessment of the level of evidence and grade of recommendation for a variety of published studies in this disease space. We update these publications and provide a summary of that original report. Results: There are no prospective randomized controlled studies to support surgical management guidelines. A risk-stratified approach based on clinical, endoscopic, and biopsy assessment allows selection of patients who could benefit from kidney-preserving procedures with oncological outcomes potentially similar to radical nephroureterectomy with bladder cuff excision, with the added benefit of renal function preservation. These treatments are aided by the development of high-definition flexible digital URS, multi-biopsies with the aid of access sheaths and other tools, and promising developments in the use of adjuvant topical therapy. Conclusions: Recent developments in imaging, minimally invasive techniques, multimodality approaches, and adjuvant topical regimens and bladder cancer prevention raise the hope for improved risk stratification and may greatly improve the endoscopic treatment for low-risk UTUC.",
keywords = "Calyces, Nephroureterectomy, Renal pelvis, Upper tract, Ureteroscopy, Urothelial cancer",
author = "Mandalapu, {Rao S.} and Mesut Remzi and {de Reijke}, {Theo M.} and Vitaly Margulis and J. Palou and A. Kapoor and Ofer Yossepowitch and Jonathan Coleman and Olivier Traxer and Anderson, {J. Kyle} and James Catto and {de la Rosette}, Jean and Timothy O’Brien and Anthony Zlotta and Matin, {Surena F.}",
year = "2016",
month = "5",
day = "27",
doi = "10.1007/s00345-016-1859-6",
language = "English (US)",
pages = "1--11",
journal = "World Journal of Urology",
issn = "0724-4983",
publisher = "Springer Verlag",

}

TY - JOUR

T1 - Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016

T2 - treatment of low-risk upper tract urothelial carcinoma

AU - Mandalapu, Rao S.

AU - Remzi, Mesut

AU - de Reijke, Theo M.

AU - Margulis, Vitaly

AU - Palou, J.

AU - Kapoor, A.

AU - Yossepowitch, Ofer

AU - Coleman, Jonathan

AU - Traxer, Olivier

AU - Anderson, J. Kyle

AU - Catto, James

AU - de la Rosette, Jean

AU - O’Brien, Timothy

AU - Zlotta, Anthony

AU - Matin, Surena F.

PY - 2016/5/27

Y1 - 2016/5/27

N2 - Introduction: The conservative management of upper tract urothelial carcinoma (UTUC) has historically been offered to patients with imperative indications. The recent International Consultation on Urologic Diseases (ICUD) publication on UTUC stratified treatment allocations based on high- and low-risk groups. This report updates the conservative management of the low-risk group. Methods: The ICUD for low-risk UTUC working group performed a thorough review of the literature with an assessment of the level of evidence and grade of recommendation for a variety of published studies in this disease space. We update these publications and provide a summary of that original report. Results: There are no prospective randomized controlled studies to support surgical management guidelines. A risk-stratified approach based on clinical, endoscopic, and biopsy assessment allows selection of patients who could benefit from kidney-preserving procedures with oncological outcomes potentially similar to radical nephroureterectomy with bladder cuff excision, with the added benefit of renal function preservation. These treatments are aided by the development of high-definition flexible digital URS, multi-biopsies with the aid of access sheaths and other tools, and promising developments in the use of adjuvant topical therapy. Conclusions: Recent developments in imaging, minimally invasive techniques, multimodality approaches, and adjuvant topical regimens and bladder cancer prevention raise the hope for improved risk stratification and may greatly improve the endoscopic treatment for low-risk UTUC.

AB - Introduction: The conservative management of upper tract urothelial carcinoma (UTUC) has historically been offered to patients with imperative indications. The recent International Consultation on Urologic Diseases (ICUD) publication on UTUC stratified treatment allocations based on high- and low-risk groups. This report updates the conservative management of the low-risk group. Methods: The ICUD for low-risk UTUC working group performed a thorough review of the literature with an assessment of the level of evidence and grade of recommendation for a variety of published studies in this disease space. We update these publications and provide a summary of that original report. Results: There are no prospective randomized controlled studies to support surgical management guidelines. A risk-stratified approach based on clinical, endoscopic, and biopsy assessment allows selection of patients who could benefit from kidney-preserving procedures with oncological outcomes potentially similar to radical nephroureterectomy with bladder cuff excision, with the added benefit of renal function preservation. These treatments are aided by the development of high-definition flexible digital URS, multi-biopsies with the aid of access sheaths and other tools, and promising developments in the use of adjuvant topical therapy. Conclusions: Recent developments in imaging, minimally invasive techniques, multimodality approaches, and adjuvant topical regimens and bladder cancer prevention raise the hope for improved risk stratification and may greatly improve the endoscopic treatment for low-risk UTUC.

KW - Calyces

KW - Nephroureterectomy

KW - Renal pelvis

KW - Upper tract

KW - Ureteroscopy

KW - Urothelial cancer

UR - http://www.scopus.com/inward/record.url?scp=84970954400&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84970954400&partnerID=8YFLogxK

U2 - 10.1007/s00345-016-1859-6

DO - 10.1007/s00345-016-1859-6

M3 - Article

C2 - 27233780

AN - SCOPUS:84970954400

SP - 1

EP - 11

JO - World Journal of Urology

JF - World Journal of Urology

SN - 0724-4983

ER -